Dr Jensen will share insights from his experiences with epidemics caused by newly emerging pathogens, and outline his current work on a clinical trial platform focused on arboviruses, including dengue fever.
A light lunch will be served at 12:30pm to in-person attendees.
Speakers
Dr Tomas Jensen Dr Jensen will share insights from his experiences with epidemics caused by newly emerging pathogens, and outline his current work on a clinical trial platform focused on arboviruses, including dengue fever. |
Opinions expressed by individuals at this event are solely of those of the individual/s and do not necessarily represent the views or opinions of the Kirby Institute or UNSW.